The vacant Novartis manufacturing facility in Suffern, New York, sold for $18 million to a buyer who then resold it to a developer for $30 million.
Catalent has agreed to pay $950 million to buy Cook Pharmica and its extensive biologics manufacturing operation in Bloomington, Indiana.
Pfizer is leaning heavily on Celltrion for biosimilar development and manufacturing, but its South Korean partner has stumbled with an FDA inspection.
Japan's Fujifilm Diosynth Biotechnologies has completed a $9 million expansion project of its cell manufacturing facilities in the U.K.
Belgium-based CDMO Kaneka Eurogentec, a unit of Japanese chemical giant Kaneka, will build a new biologics manufacturing facility.
Four weeks after Germany pulled the manufacturing authorization for a Dr. Reddy’s plant in India, it has blocked a second one.
Biocon says it has won EMA manufacturing approval for a $275 million plant in Malaysia where it will make insulin for export to the EU.
The FDA has issued a scathing warning letter to a Pfizer unit that produced EpiPens that failed during emergencies, some of them fatal.
Navesta Pharmaceuticals has opened a $9.1 million sterile manufacturing facility in Sri Lanka that is compliant with European Good Manufacturing Practices.…
Pharma giant Roche has completed the sale of its solid and liquid formulation facility in Segrate, Italy, to CMO Delpharm, which reached a deal to supply the…